http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-328089-B

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8fee1ae8c21b075aeea6b986e9f9034d
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-426
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12
filingDate 1995-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1998-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_981b5c73df8747a285a9a7bb7970b22e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0a9484191b1e3dd4be93601670e21e2
publicationDate 1998-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber TW-328089-B
titleOfInvention New azolidinediones as antihyperglycemic agents
abstract A compound according to the formula I below (I) in which R1 is C1-C4 alkyl, C3-C6 cycloalkyl, thienyl, furyl, (group) or (group) where R10 is hydrogen, C1-C4 alkyl, fluorine, chlorine, bromine, iodine, C1-C4 alkyoxy, trifluorizated C1-C4 alkyl or triflurizated C1-C4 alkoxy; R2 is hydrogen or C1-C4 alkyl; X is O or S; n is 1 or 2; A is (group) or (group) where R3 is hydrogen, C1-C4 alkyl, fluorine, chlorine, bromine, iodine, C1-C4 alkoxy, trifluorizated C1-C4 alkyl or trifluorizated C1-C4 alkoxy; B is (group) or (group) where R4 is hydrogen, C1-C4 alkyl, allyl, phenyl, phenyl-(CH2)1-2, fluorine, chlorine, bromine, iodine, or C3-C6 cycloalkyl; R5 is hydrogen, C1-C4 alkyl, phenyl, or phenyl-(CH2)1-2-; m is 0, 1, or 2; R6 is hydrogen or C1-C4 alkyl; R7 is hydrogen or C1-C4 alkyl; R8 and R9 are selected independently from hydrogen, C1-C4 alkyl, fluorine, chlorine, bromine, or iodine; Y is O or S; Z is N or CH when Y is O and Z is CH when Y is S; or a pharmaceutically acceptable salt thereof.
priorityDate 1994-05-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12271825
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14917
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420662979
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559562
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516

Total number of triples: 48.